Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosis.
Luca ProsperiniChiara MancinelliShalom HaggiagCinzia CordioliLaura De GiglioNicola De RossiSimonetta GalganiSarah RasiaSerena RuggieriCarla TortorellaCarlo PozzilliClaudio GasperiniPublished in: Journal of neurology, neurosurgery, and psychiatry (2020)
Early marginal MRI activity of one to two new T2 lesions, in the absence of both relapses and CELs, is associated with a minor risk of future disability, thus representing a simple and valuable definition for MEDA.